Delivery Order SPE2DB25D3404-SPE2DB25FUMEV

Award Date 2/26/25
Potential Completion Date 3/19/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,778.80 firm fixed-price delivery order is for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 time period, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,622.03 Firm Fixed Price delivery order is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, under a pre-existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The IDC allows for efficient government...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.06 firm fixed price contract is for the delivery of Pfizer COVID-19 vaccine doses from 2024 to 2025, with a period of performance ending on November 29, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.06 firm fixed-price delivery order is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, including a range of 6-month to 4-year doses in 0.9 mL quantities. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is a delivery order worth $1,642.75 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the provision of Pfizer COVID-19 vaccines between 2024-2025, with an ultimate completion date of November 7, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,642.75 firm fixed-price delivery order is for the supply of Pfizer COVID-19 vaccine doses, including 0.9 mL doses, for the period of June 2024 to November 2024. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds significant Indefinite Delivery...
This federal contract award, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, is for the delivery of Pfizer COVID-19 vaccines in the 2024-2025 timeframe. The $1,129.80 firm fixed-price delivery order has an ultimate completion date of January 13, 2025 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is delivering these COVID-19 vaccines to support military healthcare programs globally through the company's existing...
This is a $1,129.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pfizer COVID-19 vaccines from 2024 to 2025, with an ultimate completion date of February 18, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,129.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.81 delivery order contract is for the provision of Pfizer COVID-19 vaccines, with a period of performance from November 2024 to December 2024. The contract is a firm fixed-price, delivery order type with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMEV
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.80 firm fixed-price delivery order is for Pfizer COVID-19 vaccine doses to be delivered between 2024-2025, under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen has also been awarded a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/28/25, 11:05 AM